Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
Tyler J. Varisco,
Michael L. Johnson,
Douglas Thornton
Affiliations
Tyler J. Varisco
Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Texas, United States
Michael L. Johnson
Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, Texas, United States
Douglas Thornton
Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX 77204, United States; The Prescription Drug Misuse Education and Research Center, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX 77204, United States; Corresponding author at: Department of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy, 4849 Calhoun Rd, Houston, TX 77204, United States.
